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Gangliosides have been extensively described to be involved in the proliferation and differentiation of var-
ious cell types, such including hematopoietic cells. Our previous studies on murine models of stroma-
mediated myelopoiesis have shown that gangliosides are required for optimal capacity of stromal cells
to support proliferation of myeloid precursor cells, being shed to the supernatant and selectively incorpo-
rated into myeloid cell membranes. Here we describe the effect of gangliosides on the speciﬁc granulo-
cyte–macrophage colony-stimulating factor (GM-CSF)-induced proliferation. For that, we used the
monocytic FDC-P1 cell line, which is dependent upon GM-CSF for survival and proliferation. Cells were
cultured in the presence of GM-CSF and exogenous gangliosides (GM3, GD1a or GM1) or in the absence
of endogenous ganglioside synthesis by the use of a ceramide-synthase inhibitor, D-PDMP. We observed
that exogenous addition of GD1a enhanced the GM-CSF-induced proliferation of the FDC-P1 cells. Also,
we detected an increase in the expression of the a isoform of the GM-CSF receptor (GMRa) as well as of
the transcription factor C/EBPa. On the contrary, inhibition of glucosylceramide synthesis was accompa-
nied by a decrease in cell proliferation, which was restored upon the addition of exogenous GD1a. We also
show a co-localization of GD1a and GMR by immunocytochemistry. Taken together, our results suggest for
the ﬁrst time that ganglioside GD1a play a role on the modulation of GM-CSF-mediated proliferative
response, which might be of great interest not only in hematopoiesis, but also in other immunological
processes, Alzheimer disease, alveolar proteinosis and wherever GM-CSF exerts its effects.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Granulocyte–macrophage colony-stimulating factor (GM-CSF)
is a hematopoietic and inﬂammatory cytokine involved in cell
functions as proliferation, survival, differentiation and functional
activation, being one of the major cytokines regulating blood
homeostasis [1]. It is also therapeutically used as an adjunct to
myelosupressive chemotherapy and a potential target in leukemias
[2] and pulmonary alveolar proteinosis [3]. All functional activities
of GM-CSF are exerted through the binding of GM-CSF on its
cognate ligand, the GM-CSFR (GMR), at the surface of target cells
[4]. This process is modulated by the interaction with heparin-con-de Bioquímica, Rua Ramiro
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sevier OA license.taining proteoglycans at the cell surface, which requires an acidic
microenvironment to occur [5]. Thus, negatively charged glycolip-
ids present on the plasma membrane of target cells were proposed
to be involved in the functional role of GM-CSF [5].
GMR is a heterodimer composed of a ligand speciﬁc a chain
(GMRa) and a common b chain (bc), shared with IL-3 and IL-5
receptors, responsible for the signal transduction. Binding of
mouse GM-CSF to GMRa occurs ﬁrstly with low afﬁnity (Kd
1–100 nM) leading to the recruitment of bc, generating a high
afﬁnity GM-CSF:GMRa:bc complex (Kd 30–100 pM) which is able
to trigger the intracellular signal [4]. The transcription of GMRa
is regulated by transcription factors such as C/EBPa and PU.1,
which ultimately modulate the differentiation of hematopoietic
lineages [6–8]. In a mouse model, Rosas et al. [9] have found that
the mouse GMRa is polymorphic and alternatively spliced, gener-
ating two distinct isoforms: a transmembrane, which is able to
dimerize with bc and trigger the signal; and a soluble variant,
which lacks the transmembrane domains and result in a soluble
protein [9].
Gangliosides, sialic acid-containing glycosphingolipids, are
major components of the outer leaﬂet of mammalian plasma
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[10]. They are not homogeneously distributed on the membrane,
being rather organized in microdomains enriched in sphingolipids
and cholesterol (often described as specialized signaling platforms)
[11]. Gangliosides are largely associated to cellular processes such
as proliferation, differentiation, adhesion, migration, etc., through
the modulation of transmembrane signaling receptors [12–21]. In
the hematopoietic system, leukemic and normal cells are inﬂu-
enced by gangliosides [22,23]. In addition, it has been shown that
hematopoietic cell development is accompanied by a switch in
ganglioside proﬁle [24,25], which is also observed by increased
GM3 synthase expression and activity during differentiation of
monocytic [26,27] and megakaryocytic cells [28]. Also, the role
of membrane sialidase NEU3 was related in the modulation of
megakaryocytic K562 cells and myoblasts [29,30].
Our previous studies on murine models of stroma-mediated
myelopoiesis have shown that gangliosides are required for opti-
mal capability of stromal cells to support proliferation of myeloid
precursor cells [31–33]. Moreover, gangliosides from stromal cells
were shed to the supernatant and selectively incorporated into
myeloid cell membranes, co-localizing with the GMRa [31]. Alto-
gether, these data suggest that GM-CSF proliferative signaling
could also be under ganglioside modulation.
In this reportwedemonstrate the speciﬁcmodulation of ganglio-
sides on a GM-CSF-dependent murine myeloid precursor cell line,
FDC-P1. GD1a enhancedGM-CSF-dependent proliferation andmod-
ulated GMRa expression at both mRNA and protein levels. We also
observed a co-localization of GD1a and GMR by immunocytochem-
istry. Taken together, our results indicate that GD1a play a role on
the modulation of GM-CSF-mediated proliferative response.2. Materials and methods
2.1. Materials
We purchased RPMI 1640medium and lipid standards from Sig-
ma–Aldrich (Saint Louis, MO, USA), fetal bovine serum (FBS) from
Cultilab (Campinas, SP, Brazil), D-[U-14C]galactose (300 mCi/mmol)
from Amersham Life Science (Buckinghamshire, UK), glucosylcera-
mide synthase inhibitor D-threo-1-phenyl-2-decanoylamino-3-
morpholino-1-propanol (D-PDMP) and Fluorsave from Calbiochem
(USA). Gangliosides GM3, GD1a and GM1 from Matreya (Pleasant
Gap, PA, USA), recombinantmurine GM-CSF from PeproTech (Rocky
Hill, NJ, USA). The supernatant of DH2 hybridoma was from Glyco-
tech (USA). Human polyclonal serum anti-GD1a was kindly pro-
vided by Dr. Gustavo Nores, CIQUIBIC-Depto Química Biológica,
Facultad de Ciencias Quimicas, Universidad Nacional de Córdoba
(Córdoba, Argentina). Rabbit anti-mouse GMRa (clone M130) was
purchased from Santa-Cruz Biotechnology (USA) and anti-mouse
b-actin from Abcam (USA). Secondary ﬂuorescent antibodies anti-
mouse Alexa 488, anti-rabbit Alexa 488, anti-mouse Alexa 555
and anti-rabbit Alexa 555 were from Invitrogen (Carlsbad, CA,
USA), anti-human-FITC and Cholera toxin b-FITC from Sigma–
Aldrich (Saint Louis,MO, USA). Silicagel high performance thin layer
chromatography (HPTLC) plates from Merck (Darmstadt, Ger-
many), plastic tissue culture dishes fromNunc (Roskilde, Denmark).
Cell Titer Aqueous Solution was from Promega (Madison, USA).
ECL-chemiluminescence detection kit from Perkin Elmer, USA.2.2. Cells
Murine myeloid precursor cell lineage, FDC-P1, was obtained
from Rio de Janeiro Cell Bank (PABCAM, Federal University, Rio
de Janeiro, RJ, Brazil). Cells were maintained in RPMI 1640
(10%FBS) supplemented with murine GM-CSF (2 ng/ml), at 37 Cin 5% CO2 humidiﬁed atmosphere. To determine the optimal cyto-
kine concentration, cells were incubated with 0.2–10 gg/ml of
GM-CSF.
2.3. Proliferation assay and ganglioside treatment
For these evaluations, 3  104 cells were seeded on 96 well
plates in 100 lL RPMI (10%SFB) containing or not GM-CSF (0–
10 ng/ml) and 20 lM of gangliosides GM3, GM1 or GD1a for
24 h. Proliferation was assessed by Cell Titer Aqueous Assay
(MTS) as a measure of absorbance at 490 nm quantiﬁed by spectro-
photometry in Spectramax 190 (Molecular Devices, USA).
2.4. Endogenous ganglioside synthesis inhibition
For this experiment, 5  105 cells were seeded on a six well
plate and cultured for 48 h in 3 mL RPMI (10%FBS) containing
GM-CSF (2 ng/ml) and the glucosylceramide synthase inhibitor,
D-PDMP (10 lM). Cell viability during inhibition was accessed by
hemocytometer counting with Trypan Blue exclusion dye.
2.5. Metabolic labeling and lipid extraction
D-PDMP-treated and control cells were incubated with [14C]gal-
actose (1 lCi/mL) for the last 12 h of culture. Cells were washed in
cold PBS and brieﬂy centrifuged. Lipids were extracted from the
pellet with methanol:chloroform (2:1, v/v). Gangliosides were
puriﬁed by Sepak C18 [40]. HPTLC analysis was performed with
two successive systems chloroform:methanol (4:1, v/v) and chlo-
roform:methanol:calcium chloride 0.25% (60:36:8). The second
migration was run in a TLC tank designed by Nores et al. [41].
Radioactive bands were visualized by autoradiography of chro-
matographic ﬁlm, identiﬁed by co-chromatographed standards
and quantiﬁed by densitometry. Standards were visualized by
Resorcinol-HCl.
2.6. Immunoﬂuorescence microscopy
Cells were washed twice with PBS and pelleted over coverslips
using a micro plate centrifuge, ﬁxed in paraformaldehyde 4% for
30 min at 37 C, washed in PBS and incubated in 3% BSA/PBS buffer
for 1 h at 37 C to block non-speciﬁc binding sites. Coverslips were
then incubated overnight at room temperature with primary anti-
bodies, washed with PBS buffer, and exposed to secondary anti-
bodies for 1.5 h at 37 C. The primary antibodies were: polyclonal
rabbit anti-mouse GMRa (1:50), polyclonal rabbit anti-mouse-bc
(1:50), monoclonal mouse anti-GM3 (clone DH2) 20%, human
polyclonal serum anti-GD1a. Secondary antibodies were Alexa
488- or Alexa 555-conjugated goat anti-mouse antibodies, Alexa
488- or Alexa 555-conjugated anti-rabbit antibodies (10 lg/mL).
After ﬁnal washes with PBS, coverslips were mounted in Fluor-
save. Confocal images were obtained using a FV1000 Olympus
microscope. Quantitative data of colocalization events were deter-
mined by the Person’s correlation coefﬁcient and the overlap coef-
ﬁcient according to Manders, determined by FV1000 Software,
ver.2.0. Thresholds discriminating between signal and background
were chosen using cells stained only with second antibody. Voxels
with signal intensity above threshold level in both channels (over-
lap) were taken as intensity in additive colors (yellow = green and
red).
2.7. RT-PCR, qRT-PCR and Western blotting
Total mRNA was extracted using TRIzol according to supplier
instructions (Invitrogen). cDNA was synthesized by reverse tran-
scription using 1 ug of oligo(dT), primer T23V (50TTT TTT TTT TTT
Table 1
Densitometric analysis of metabolically labeled gangliosides from FDC-P1 cells
treated or not with D-PDMP.
Ganglioside relative content (% of total radioactivity in control)
Gangliosides Control D-PDMP % of Inhibition
GM3 3.60 1.64 54.4
GM2 5.77 0.55 90.5
GM1 33.09 18.44 44.3
GD3 3.94 2.02 48.7
GD1a 40.70 30.27 25.6
GD1b 10.88 5.16 47.7
GT1b 2.00 0.30 85.0
Total 100 58.38
Cells were cultured for 48 h in medium containing 2 gg/ml GM-CSF in the presence
or not of the glucosylceramide synthase inhibitor, D-PDMP (10 lM). In the last 12 h,
[14C]-galactose (1 lCi/ml) was added. Lipids were extracted, puriﬁed, analyzed by
HPTLC and visualized by ﬂuorography. Results are expressed as percentage of total
radioactivity incorporated in gangliosides in control group. Representative data
from triplicates are shown. GT1b, GD1b, GD1a, GD3, GM1, GM2 and GM3 are
gangliosides.
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composed of a cycle of 60 min at 42 C. RT-PCR was done with
primers listed in Table 2. The reaction was composed of an initial
cycle of 94 C for 5 min, followed by 40 cycles of 10 s at 94 C,
15 s at 60 C and 15 s at 72 C. qRT-PCR was done using StepOne
Plus real-time PCR system (Applied Biosystems) Primers sequences
were designed using Primer3 software [42] and detection was
done with SybrGreen. Reaction was composed of an initial cycle
of 94 C for 5 min, followed by 40 cycles of 10 s at 94 C, 15 s at
60 C and 15 s at 72 C. Samples were kept at 40 C for 2 min for
renaturation and the temperature was raised from 55 to 95 C
(1 C/s) to generate the denaturation curve of the ampliﬁed prod-
ucts. All results were analyzed by the method of 2DDCT [43] using
b-actin (b ACT) as housekeeping gene.
For immunoblot analysis, control and treated cells were lysed in
Tris–HCl buffer (pH 6.8) with 2% SDS, 10% glycerol and 2-b-
mercaptoethanol. Equal amounts of protein were separated on
10% SDS–PAGE, transferred to nitrocellulose membranes (Hybond
ECL Nitrocellulose Membrane, Amersham, USA) and probed over-
night with polyclonal rabbit antibody against human GMRa
(1:200, clone M130), incubated with HRP conjugated anti-rabbit-
IgG antibody (Cell Signaling Technology, USA) and detected by
chemiluminescence (PerkinElmer Life Sciences) on X-ray ﬁlm.
Membranes were stripped in NaOH 1 M for 10 min and blotted
against -beta-actin (1:5000). Western blots bands intensities were
quantiﬁed by densitometry using Alpha Ease FC software (version
6.0.0).
2.8. Protein determination
Protein contents were measured by the method of Peterson [44]
using bovine serum albumin as standard.
2.9. Statistical analysis
Data were expressed as mean ± standard error, p < 0.05 was
considered signiﬁcant. Statistical comparisons were performed byTable 2
Primers used in this study.
Primer forward
GMRa transmembrane 50-GCT ACG AAG GCG CTC GAG-3
GMRa soluble 50-CGG GAA TTG TGA GTG ACA G
C/EBPa 50-CCG ACT TCT ACG AGG TGG A
b-Actin 50-TAT GCC AAC ACA GTT CGT GStudent’s T test and, as appropriated, by one or two way ANOVA
and S.N.K. post hoc test. All analyzes were performed with the SPSS
statistical package (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Exogenous addition of ganglioside GD1a or GM3 increases
GM-CSF-induced cell proliferation
The optimal GM-CSF concentration for proliferation assay was
determined as 2 ng/ml (Fig. 1a). To determine whether pure exog-
enous gangliosides can modulate the mitogenic activity of GM-CSF
on FDC-P1 cells, we incubated cells with 2 ng/ml of GM-CSF and
20 lM of GM3, GD1a or GM1 for 24 h. GD1a or GM3 showed stim-
ulatory effects over the GM-CSF induced FDC-P1 proliferation.
GM1-treated cells showed no increase in proliferation. There was
no independent effect of gangliosides (Fig. 1b).
3.2. Inhibition of ganglioside synthesis by D-PDMP
To study the role of cellular gangliosides in GM-CSF-induced
cell proliferation, we inhibited ganglioside synthesis by the use
of a glucosylceramide synthase inhibitor, D-PDMP. FDC-P1 cells
normally synthesize gangliosides GD1a and GM1 as major ganglio-
sides, and to a lesser extent, GM3, GM2, GD3, GD1b and GT1b [31].
We cultured cells in medium containing 10 lM D-PDMP for 48 h.
During the ﬁnal 12 h [14C]-galactose (0.5 lCi/mL) was added to
the culture medium. Densitometric analysis of HPTLC autoradio-
gram demonstrated a markedly reduction (40%) in the total gangli-
oside synthesis (Table 1). Notably, the GD1a synthesis was reduced
only 25%.
3.3. Decreased GM-CSF-induced proliferation by reduced ganglioside
synthesis
We next determined the role of gangliosides inhibition on FDC-
P1 proliferation and viability (Fig. 2). As expected, GM-CSF induced
the proliferation of FDC-P1 cells. However, when cells were co-
incubated with the inhibitor D-PDMP, there was a signiﬁcant
growth arrest. Non-treated cells or vehicle treated (ethanol 0.1%,
data not shown) had no effect on cell proliferation.
There was a signiﬁcant decrease in cell proliferation after the
48 h of ganglioside synthesis inhibition, compared to the GM-CSF
control group. Ethanol 0.1% as vehicle had no toxic effect as well
(data not shown).
3.4. Exogenous GD1a addition restored proliferative response of
D-PDMP treated cells
To assess the contribution of individual gangliosides on the pro-
liferative response to GM-CSF, we performed an assay in which
cells were pretreated with D-PDMP for 48 h to reduce endogenous
ganglioside content and then maintained for additional 24 h in (i)
standard medium (GM-CSF); (ii) inhibition medium (GM-CSF and
D-PDMP); (iii) inhibition medium with GD1a; (iv) inhibition med-
ium with GM3 (Fig. 3). Interestingly, exogenous addition ofPrimer reverse
0 50-CCA CTG GAC CTC AAA CTG GA-30
C-30 50-CCA CTG GAC CTC AAA CTG GA-30
G-30 50-GTC GAT GTA GGC GCT GAT GT-30
TC TGG-30 50-TAC TCC TGC TTG CTG ATC CAC AT-30
Fig. 1. GD1a and GM3 enhance FDC-P1 proliferative response to GM-CSF. (a) Cells were incubated in RPMI (10% FBS) containing 0.02–2 ng/ml GM-CSF for 24 h. (b) Cells were
incubated in RPMI (10% FBS) containing 2 ng/ml GM-CSF and 20 lM gangliosides (each) for 24 h. Proliferation was measured with Cell Titer Aqueous Solution Proliferation
Assay (MTS). Results are expressed as absorbance in 490 nm ± SE of quadruplicates. Seeding density for FDC-P1 was 3  104/well. (⁄) p < 0.05, different from GM-CSF group.
Two-way ANOVA + SNK.
Fig. 2. Cell proliferation during ganglioside synthesis inhibition. 1  105 cells were
maintained in RPMI 10% FBS only (no GM-CSF), RPMI 10% FBS containing 2 ng/ml
GM-CSF (GM-CSF) or RPMI 10% FBS containing 2 ng/ml GM-CSF and 10 lM D-PDMP
for 48 h. Proliferation and viability were assessed by cell counting in hemocytom-
eter with Trypan Blue. Results are mean ± SE of triplicates.
Fig. 3. GD1a restores proliferation of D-PDMP treated cells. 3  104 cells pretreated
with 10 lM D-PDMP for 48 h were washed to remove inhibitor and further
incubated with 2 ng/ml GM-CSF (GM-CSF, non-inhibited cells); 2 ng/ml GM-CSF
and 10 lM D-PDMP (D-PDMP); 2 ng/ml GM-CSF + 10 lM D-PDMP and 20 lM GD1a
(D-PDMP GD1a); 2 ng/ml GM-CSF + 10 lM D-PDMP and 20 lM GM3 (D-PDMP GM3).
Proliferation was measured with Cell Titer Aqueous Solution Proliferation Assay
(MTS). Results are expressed as absorbance in 490 nm ± SE of quadruplicates. (⁄)
p < 0.05 different from D-PDMP, D-PDMP GM3. Student’s T test.
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gesting that an adequate proliferative response to the GM-CSF
might be dependent of speciﬁc cellular ganglioside content.
3.5. GD1a modulates the expression of the transmembrane GMRa
isoforms
A previous report [9] has shown that mouse GMRa is polymor-
phic, being expressed as two spliced variants. In this regard, we
asked if FDC-P1 cells would also express both variants of the
GM-CSFRa chain receptor. As shown in Fig. 4a, FDC-P1 cells
express both the transmembrane and the soluble forms.
We also found that the two isoforms were differentially
modulated with the addition of GM-CSF. The quantiﬁcation of
GMRa transmembrane expression is under positive modulation
of GM-CSF (Fig. 4b) being more expressed under a suboptimal
concentration of cytokine (0.2 ng/ml); and less expressed as the
concentration increases. This result is in agreement with the prolif-
eration curve (Fig. 1a) where we observed that 2 ng/ml GM-CSF is
the optimal concentration to induce proliferation, therefore sug-
gesting a down-regulation effect on the growth-factor receptor
expression. The expression of the alternative spliced soluble vari-
ant had a much less pronounced variation with increasing cytokine
concentrations.In order to analyze the effect of ganglioside enrichment on GMR
expression, we treated cells with GM-CSF and different ganglio-
sides for 24 h. GD1a treatment differently increased the expression
of GMRa transmembrane over the soluble isoform (Fig. 5a). We
next assessed if this transcriptional effect was reﬂected at the pro-
tein level, and we observed higher levels of the transmembrane
GMRa compared to the GM-CSF control group (Fig. 5b), corroborat-
ing our gene expression result.
3.6. C/EBPa transcription factor is also positively regulated by GD1a
In order to determine if our treatment with GM-CSF + GD1a
would also increase the expression of C/EBPa, we performed quan-
titative RT-PCR. As expected, increased levels of C/EBPa mRNA are
observed in GM-CSF + GD1a treated cells (Fig. 6).
3.7. GD1a colocalizes with GMR in FDC-P1 cells
Since the response of GM-CSF requires its association with
GMR, we investigated the distribution of GD1a and GM3 with
Fig. 4. Detection of GMRa transmembrane and soluble isoforms. (a) RT-PCR analysis of GMRa isoforms mRNA expression by FDC-P1 cells grown in RPMI medium containing
2 ng/ml GM-CSF. Ampliﬁed products of approximately 151 and 171 bp are shown, corresponding to transmembrane and soluble isoforms. Representative image from four
independent experiments. (b) qRT-PCR analysis of FDC-P1 cells treated with GM-CSF (0.2–20 ng/ml). Beta-actin was used as housekeeping gene. Values were normalized by
the group GM-CSF (2 ng/ml). Results are Mean ± SE from triplicates.
Fig. 5. GD1a induces expression of GMRa transmembrane isoform. (a) qRT-PCR analysis of FDC-P1 cells treated with GM-CSF (2 ng/ml) and gangliosides GM3, GD1a and GM1
(20 uM each) for 24 h. Values were normalized by the group GM-CSF (2 ng/ml). (b) Immunodetection of GMRa. Cell were treated with GM-CSF (2 ng/ml) and gangliosides
GD1a (20 lM) for 24 h. Results are Mean ± SE from triplicates.
Fig. 6. GD1a increases relative expression of C/EBPa. qRT-PCR analysis of FDC-P1
cells treated with GM-CSF (2 ng/ml) and gangliosides GM3 and GD1a (20 lM each)
for 24 h. Results are Mean ± SE from triplicates. (⁄) Differs from GM-CSF (p < 0.05),
Student’s T test.
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dance with TLC analysis (Table 1), FDC-P1 cells showed a high con-
tent of GD1a. By immunocytochemistry, mostly of GD1a was
localized in the plasma membrane (Fig. 7b and f). GMRa and bc
had a similar distribution, slightly enriched at the plasma mem-
brane (Fig. 7a and e). In merged images, there were areas of colo-
calization for both receptor subunits with GD1a (Fig. 7c and g).
Colocalization coefﬁcients for GD1a/GMRa were 0.83 and 0.95and for GD1a/GMRbwere 0.82 and 0.92 using Pearson’s correlation
coefﬁcient and Manders’ overlap coefﬁcient, respectively. Con-
versely, barely detectable labeling with anti-GM3 (DH2) was
found. Despite the low cellular content, GM3 colocalizes with
GMRa (Pearson’s coefﬁcient = 0.66 and Manders’ overlap coefﬁ-
cient = 0.98) (not shown).4. Discussion
The present study addressed for the ﬁrst time the inﬂuence of
ganglioside on the GM-CSF-induced myeloid proliferation. Based
on our previous observations regarding the role of gangliosides in
the myelosupportive capacity of stromal cells [31–33], we
hypothesized here that gangliosides inﬂuence GM-CSF induced
proliferation. We compared the GM-CSF-induced proliferation by
complementary approaches of adding exogenous gangliosides to
the GM-CSF-containing culture media as well as inhibiting endog-
enous synthesis by the use of a glucosylceramide synthase inhibi-
tor, D-PDMP. We found that ganglioside enrichment with GM3 or
GD1a synergistically enhanced the GM-CSF-induced proliferation.
Inhibition of glucosylceramide synthase by D-PDMP treatment
caused reduction in ganglioside synthesis and retarded cell prolif-
eration. Interestingly, the reduction in ganglioside synthesis was
not indiscriminate. Amongst the synthesized gangliosides, GD1a
was less affected, suggesting a differential role for this ganglioside
in FDC-P1 cells. This is in accordance with the strong restoring
Fig. 7. Confocal immunoﬂuorescence microscopy of GMRa and -b chain and ganglioside GD1a. Colocalization of GD1a (green, b and f) and GMRa (red, a) or bc (red, e) are
revealed by the overlap of signals resulting in yellow staining (c and g). Colocalization mask showing overlapping regions of red and green (d and h). Fluorescence intensity
along the line showed in each image is plotted in the inset graphs with green and red curve, respectively. Scale bar, 10 lm (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.).
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PDMP-treated cells. Gangliosides have been extensively associated
to growth factor receptor modulation, acting through clusters of
glycosphingolipids enriched domains in the plasma membrane
that would work as signaling platforms [34,35]. Here, we observed
high colocalization coefﬁcients for GD1a and GMRa by immunocy-
tochemistry and confocal microscopy analyses.
Transcriptional variants for cytokine receptors, such as IL-5R
and GMRa, were described [9,36]. The differential expression be-
tween the two IL-5R isoforms is modulated by cytokines, favoring
the expression of one isoform in detriment of the other. In this
work we identiﬁed two transcribed isoforms of mouse GMRa and
we showed that their differential expression is under modulation
of GM-CSF concentration. Recent results suggest that gangliosides
could enhance cell sensitivity to growth factors, in that, membrane
ganglioside enrichment may facilitate cellular responses by acting
as an ampliﬁcation mechanism, especially for suboptimal growth
factor concentrations [34,35]. Although several studies reported
an association of ganglioside expression with hematopoietic pro-
cesses of proliferation and differentiation, so far, no study has de-
scribed a speciﬁc effect of gangliosides in GM-CSF-induced myeloid
proliferation. Remarkably, we showed that ganglioside treatmentcan interfere at the transcriptional control of GMRa. The addition
of ganglioside GD1a increased the expression of the transmem-
brane isoform, in agreement with the augmented expression of
one of its major transcription factor C/EBPa [7,37], ultimately
increasing the protein levels of GMRa transmembrane isoform.
Although the precise molecular mechanism by which ganglio-
sides modulate GM-CSF induced proliferation remains unclear,
our results provide major starting points for a more detailed
understanding. The recruitment of speciﬁc transcription factors
governed by GM-CSF could inﬂuence the alternative splicing and
determine which receptor isoform to be expressed, rendering the
cells more responsive to GM-CSF, and thus, controlling its
proliferation.
In the last years, many studies considering the modulation of
growth factor signaling by gangliosides have been done in a num-
ber of different cell types with distinct ganglioside species and
experimental conditions. Although several studies reported an
association of ganglioside expression with hematopoietic pro-
cesses of proliferation and differentiation, so far, no study has de-
scribed a speciﬁc effect of gangliosides in GM-CSF-induced myeloid
proliferation. In the hematopoietic context, the present work is in
accordance with previous studies with stromal cells, where it
606 A.X.S. Santos et al. / Cytokine 56 (2011) 600–607was shown that the biological activity of GM-CSF-producing stro-
mas depends upon tissue cofactors, including capping of both hep-
aran-sulfate proteoglycans [38] and gangliosides [5,31–33] at the
interface between hematopoietic and stromal cells. These aggre-
gates possibly generate a permissive signaling microdomain,
where the increased amount of sialic acid could be related to local
decrease in pH necessary for the interaction of heparan-sulfate and
GM-CSF [5,38].
Finally, this work presents as a major ﬁnding the unprecedented
role of gangliosides, speciﬁcally GD1a, in the GM-CSF-induced pro-
liferation and the modulation of GMRa expression. The role of gan-
gliosides in modulating biological processes has gained much
attention in the past decade and these results consist of an impor-
tant piece of contribution to the understanding of the effect of gan-
gliosides on GM-CSF biological effects. It is important to note that
this may be of great interest not only in hematopoiesis, but also in
other immunological processes, Alzheimer disease [39], alveolar
proteinosis [3] and wherever else GM-CSF exerts its effects.
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